Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7)

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Draz, Nehal ^a   Datta, Sumona ^a   Webster, Daniel P ^a   Cropley, Ian ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; TUBERCULOSTATIC AGENT; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRESS SYNDROME; DRUG ERUPTION; DRUG FEVER; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 7; LABORATORY TEST; LETHARGY; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LYMPHOCYTOSIS; MACULOPAPULAR RASH; MONOCYTOSIS; MYALGIA; NONHUMAN; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; TUBERCULOUS CERVICAL LYMPHADENITIS; TUBERCULOUS LYMPHADENITIS; VIRUS DETECTION; VIRUS REACTIVATION; COMPLICATION; DRUG HYPERSENSITIVITY SYNDROME; EXANTHEMA SUBITUM;

ADULT; ANTITUBERCULAR AGENTS; DRUG HYPERSENSITIVITY SYNDROME; FEMALE; HERPESVIRUS 7, HUMAN; HUMANS; ROSEOLOVIRUS INFECTIONS;

EID: 84883035707     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-010348     Document Type: Article

References (15)

1. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011;124:588-97.
2. Criado PR, Avancini J, Santi CG, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system. Isr Med Assoc J 2012;14:577-82.
3. Oskay T, Karademir A, Erturk OI. Association of anticonvulsant hypersensitivity syndrome with herpesvirus 6, 7. Epilepsy Res 2006;701:27-40. (Pubitemid 43947513)
4. Seishima M, Yamanaka S, Fujisawa T, et al. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006;1552:344-9. (Pubitemid 44050568)
5. Picard D, Janela B, Descamps V, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010;2:46ra62.
6. Ushigome Y, Kano Y, Hirahara K, et al. Human herpesvirus 6 reactivation in drug-induced hypersensitivity syndrome and DRESS validation score. Am J Med 2012;125:e9-10.
7. Shiohara T, Iijima M, Ikezawa Z, et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156:1083-4. (Pubitemid 46642847)
8. Hara H, Kobayashi M, Yokoyama A, et al. Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7. Dermatology 2005;211:159-61. (Pubitemid 41160255)
9. Morito H, Kitamura K, Fukumoto T, et al. Drug eruption with eosinophilia and systemic syndrome associated with reactivation of human herpesvirus 7, not human herpesvirus 6. J Dermatol 2012;39:669-70.
10. Camous X, Calbo S, Picard D, et al. Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis. Curr Opin Immunol 2012;24:730-5.
11. Yagami A, Yoshikawa T, Asano Y, et al. Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpes 7. Dermatology 2006;213:341-4. (Pubitemid 44837025)
12. Ganeva M, Gancheva T, Lazarova R, et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 2008;478:853-60.
13. Palmero D, Castagnino J, Musella RM, et al. Difficult clinical management of anti-tuberculosis DRESS syndrome [Case study]. Int J Tuberc Lung Dis 2013;17:76-8.
14. Lee JH, Park HK, Heo J, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci 2008;23:521-5.
15. Rodríguez R, Jover V, Orozco I, et al. DRESS syndrome in a 19-year-old patient following the administration of first-line antituberculosis drugs. J Investig Allergol Clin Immunol 2012;22:380.